Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Kidney Disease, Secondary Hyperparathyroidism”

192 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 192 results

Not applicableStudy completedNCT01149291
What this trial is testing

Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
AbbVie (prior sponsor, Abbott) 511
Testing effectiveness (Phase 2)Study completedNCT02977117
What this trial is testing

The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis

Who this might be right for
Endstage Renal Disease
Iain Bressendorff 59
Large-scale testing (Phase 3)Study completedNCT00345839
What this trial is testing

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 3,883
Not applicableNot Yet RecruitingNCT07151664
What this trial is testing

Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesEnd Stage Renal Failure
West China Hospital 60
Large-scale testing (Phase 3)Study completedNCT01219855
What this trial is testing

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismVitamin D Insufficiency
OPKO Health, Inc. 78
Early research (Phase 1)Study completedNCT02833857
What this trial is testing

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

Who this might be right for
Chronic Kidney Disease, Secondary Hyperparathyroidism
Amgen 11
Not applicableStudy completedNCT01081665
What this trial is testing

Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary Hyperparathyroidism

Who this might be right for
Chronic Kidney FailureSecondary Hyperparathyroidism
Abbott 237
Not applicableStudy completedNCT00995163
What this trial is testing

Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease

Who this might be right for
End Stage Renal DiseaseHyperparathyroidism, Secondary
Kyowa Kirin Co., Ltd. 8,020
Testing effectiveness (Phase 2)Study completedNCT00042432
What this trial is testing

Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

Who this might be right for
Secondary HyperparathyroidismChronic Renal Insufficiency
Amgen 54
Large-scale testing (Phase 3)Study completedNCT05836220
What this trial is testing

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2

Who this might be right for
Secondary HyperparathyroidismEnd Stage Kidney Disease
Pathalys Pharma 412
Testing effectiveness (Phase 2)Ended earlyNCT03960554
What this trial is testing

The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients

Who this might be right for
OsteoporosisRenal OsteodystrophyKidney Transplant; Complications
Thomas Nickolas, MD MS 8
Not applicableUnknownNCT04564924
What this trial is testing

To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI

Who this might be right for
Chronic Kidney Disease-Mineral and Bone Disorder
Tongji Hospital 200
Early research (Phase 1)Study completedNCT01290029
What this trial is testing

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, SecondarySecondary Hyperparathyroidism
Amgen 14
Large-scale testing (Phase 3)Study completedNCT01704079
What this trial is testing

Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, SecondaryVitamin D Deficiency
OPKO IP Holdings II, Inc. 216
Not applicableLooking for participantsNCT07368946
What this trial is testing

Phosphate Assessment in Chronic Kidney Disease Patients Study

Who this might be right for
Chronic Kidney Disease (Stage 3-4)Chronic Kidney Disease Mineral and Bone Disorder
University of Texas Southwestern Medical Center 60
Post-approval studies (Phase 4)Study completedNCT00528788
What this trial is testing

How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis

Who this might be right for
Hyperparathyroidism, SecondaryKidney Failure, Chronic
Duke University 24
Not applicableStudy completedNCT02708368
What this trial is testing

SOP's for CKD-MBD-Biomarkers

Who this might be right for
Chronic Kidney Diseases
RWTH Aachen University 32
Not applicableLooking for participantsNCT06571344
What this trial is testing

Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management

Who this might be right for
Vitamin D Deficiency Due to Chronic Kidney Disease
Medical University of Gdansk 160
Testing effectiveness (Phase 2)Study completedNCT03960437
What this trial is testing

The Effect of Etelcalcetide on CKD-MBD

Who this might be right for
Chronic Kidney Disease Mineral and Bone DisorderRenal OsteodystrophyVascular Calcification+1 more
Thomas Nickolas, MD MS 22
Large-scale testing (Phase 3)Study completedNCT01071070
What this trial is testing

Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Abbott 216
Load More Results